82 related articles for article (PubMed ID: 7636454)
1. Patient preferences for migraine therapy: subcutaneous sumatriptan compared with other medications.
Luciani RJ; Osterhaus JT; Gutterman DL
J Fam Pract; 1995 Aug; 41(2):147-52. PubMed ID: 7636454
[TBL] [Abstract][Full Text] [Related]
2. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
[TBL] [Abstract][Full Text] [Related]
4. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
[TBL] [Abstract][Full Text] [Related]
6. Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes.
Cohen JA; Beall D; Beck A; Rawlings J; Miller DW; Clements B; Pait DG; Batenhorst A
Clin Ther; 1999 Jan; 21(1):190-204. PubMed ID: 10090435
[TBL] [Abstract][Full Text] [Related]
7. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
Landy SH; McGinnis JE; McDonald SA
Headache; 2005 Apr; 45(4):346-9. PubMed ID: 15836571
[TBL] [Abstract][Full Text] [Related]
8. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial.
Goldstein J; Silberstein SD; Saper JR; Elkind AH; Smith TR; Gallagher RM; Battikha JP; Hoffman H; Baggish J
Headache; 2005 Sep; 45(8):973-82. PubMed ID: 16109110
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
[TBL] [Abstract][Full Text] [Related]
10. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
Solbach MP; Waymer RS
Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous sumatriptan in acute treatment of migraine: a multicentre New Zealand trial.
Thomson AN; Arthur GP; Bergin PS; Pollock M; Parkin PJ; Flanagan M; Samson SA
N Z Med J; 1993 May; 106(955):171-3. PubMed ID: 8389026
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines.
Friedman BW; Hochberg M; Esses D; Bijur PE; Corbo J; Paternoster J; Solorzano C; Toosi B; Lipton RB; Gallagher EJ
Headache; 2006 Jun; 46(6):934-41. PubMed ID: 16732839
[TBL] [Abstract][Full Text] [Related]
13. [Subcutaneous sumatriptan in the treatment of migraine attacks. An analysis of its long term efficaciousness and tolerance].
Leira R; Suárez C; Castillo J; Lema M; Noya M
Rev Neurol; 1995; 23(122):752-5. PubMed ID: 7497233
[TBL] [Abstract][Full Text] [Related]
14. Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.
Sheftell FD; Feleppa M; Tepper SJ; Volcy M; Rapoport AM; Bigal ME
Headache; 2004; 44(7):661-8. PubMed ID: 15209687
[TBL] [Abstract][Full Text] [Related]
15. Improvements in health-related quality of life with sumatriptan treatment for migraine.
Jhingran P; Cady RK; Rubino J; Miller D; Grice RB; Gutterman DL
J Fam Pract; 1996 Jan; 42(1):36-42. PubMed ID: 8537803
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
Stepień A
Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the efficacy of migraine therapy.
Chawluk JB
Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
[TBL] [Abstract][Full Text] [Related]
18. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
19. Satisfaction with current migraine therapy: experience from 3 centers in US and Sweden.
Bigal M; Rapoport A; Aurora S; Sheftell F; Tepper S; Dahlof C
Headache; 2007 Apr; 47(4):475-9. PubMed ID: 17445096
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
